COMP <GO>
OSS vs ZEPP // REVENUE GROWTH (YOY)
One Stop Systems Inc. (NASDAQ) VS. Zepp Health Corporation each representing sixteen (Class A) (NYSE) • 15-METRIC TALLY: OSS 6
— ZEPP 2
▲ REVENUE GROWTH (YOY) LEADER: ZEPP
LAST: $5.82 (-6.88%) • MKT CAP: $145.7M
revenue-growth
31.20%
ZEPP — Zepp Health Corporation each representing sixteen (Class A) SUPERIOR
ROARABLE D- • RQD 35/100
LAST: $2.25 (-3.85%) • MKT CAP: $33.0M
revenue-growth
41.80%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OSS VS. ZEPP)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | OSS | ZEPP | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 49.60% | 38.30% | +11.30 | OSS | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -18.00% | -14.70% | -3.30 | ZEPP | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -10.50% | -11.30% | +0.80 | OSS | /operating-margins <GO> |
| Net Profit Margin | 15.80% | -15.50% | +31.30 | OSS | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 31.20% | 41.80% | -10.60 | ZEPP | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 13.81 | 0.33 | +13.48 | OSS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 5/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 26.6 | 11.4 | +15.17 | OSS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 24.0x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $145.7M | $33.0M | $112.7M | OSS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | OSS REV | ZEPP REV | OSS GROSS % | ZEPP GROSS % | OSS FCF | ZEPP FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $32.2M | $258.9M | 49.6% | 38.3% | — | -$26.2M |
| FY 2024 | $24.6M | $182.6M | 2.5% | 38.5% | -$336.4K | -$25.8M |
| FY 2023 | $60.9M | $352.9M | — | — | -$439.7K | $42.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OSS // BETA —
ZEPP // BETA —